SM
Shrikant Mohanlal Dalwadi
About Shrikant Mohanlal Dalwadi
Data last updated:
Shrikant Mohanlal Dalwadi is a Director at Croon Pharma Private Limited (since 2023) and Director at Eye And U Ophthalmic Private Limited (since 2013). The companies operate in Pharma and Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jun 2023 | 2023 | Active | ||
| Director | 30 Jul 2013 | 2013 | Active |
Board colleagues of Shrikant Mohanlal Dalwadi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dinesh Ranchhoddas Ravani | 10221386 | Croon Pharma Private Limited | Director |
| Kaushik Ishvarbhai Solanki | 06631435 | Croon Pharma Private Limited , Eye And U Ophthalmic Private Limited | Director |
| Shiv Shantilal Malli | 09178505 | Croon Pharma Private Limited | Director |
| Amit Manubhai Patel | 06631431 | Eye And U Ophthalmic Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shrikant Mohanlal Dalwadi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shrikant Mohanlal Dalwadi
Shrikant Mohanlal Dalwadi currently holds 2 directorships: Croon Pharma Private Limited (Director, since 30 Jun 2023); Eye And U Ophthalmic Private Limited (Director, since 30 Jul 2013).
Shrikant Mohanlal Dalwadi was first appointed on 30 Jul 2013 as Director at Eye And U Ophthalmic Private Limited. The most recent appointment on record is 30 Jun 2023 at Croon Pharma Private Limited.
The current boards of Shrikant Mohanlal Dalwadi's companies include Dinesh Ranchhoddas Ravani (Croon Pharma Private Limited), Kaushik Ishvarbhai Solanki (Croon Pharma Private Limited), Shiv Shantilal Malli (Croon Pharma Private Limited), Amit Manubhai Patel (Eye And U Ophthalmic Private Limited).